577 related articles for article (PubMed ID: 25412984)
1. Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.
Iwata T; Yoshida S; Nagato K; Nakajima T; Suzuki H; Tagawa T; Mizobuchi T; Ota S; Nakatani Y; Yoshino I
Surg Today; 2015 Oct; 45(10):1263-70. PubMed ID: 25412984
[TBL] [Abstract][Full Text] [Related]
2. Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
Iwata T; Yoshida S; Fujiwara T; Wada H; Nakajima T; Suzuki H; Yoshino I
Ann Thorac Surg; 2016 Dec; 102(6):1905-1910. PubMed ID: 27546601
[TBL] [Abstract][Full Text] [Related]
3. Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis.
Sekihara K; Aokage K; Miyoshi T; Tane K; Ishii G; Tsuboi M
Surg Today; 2020 Aug; 50(8):905-911. PubMed ID: 32144483
[TBL] [Abstract][Full Text] [Related]
4. Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis.
Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Kuwata T; Imanishi N; Yoneda K; Kuroda K; Tanaka F
Surg Today; 2020 May; 50(5):469-474. PubMed ID: 31773277
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
7. Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone.
Miura Y; Saito T; Tanaka T; Takoi H; Yatagai Y; Inomata M; Nei T; Saito Y; Gemma A; Azuma A
Respir Investig; 2018 Jan; 56(1):72-79. PubMed ID: 29325685
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Yamamoto Y; Yano Y; Kuge T; Okabe F; Ishijima M; Uenami T; Kanazu M; Akazawa Y; Yamaguchi T; Mori M
Thorac Cancer; 2020 Nov; 11(11):3317-3325. PubMed ID: 32986306
[TBL] [Abstract][Full Text] [Related]
9. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study.
Sato S; Shimizu Y; Goto T; Kitahara A; Koike T; Ishikawa H; Watanabe T; Tsuchida M
BMC Pulm Med; 2018 Aug; 18(1):134. PubMed ID: 30097033
[TBL] [Abstract][Full Text] [Related]
10. Uniportal video-assisted thoracic surgery and perioperative pirfenidone for lung cancer and idiopathic pulmonary fibrosis: a case report.
Saiki A; Mizobuchi T; Nagato K; Ishibashi F; Tsuyusaki J; Sugano I
J Int Med Res; 2021 Sep; 49(9):3000605211016998. PubMed ID: 34521243
[TBL] [Abstract][Full Text] [Related]
11. Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.
Tanaka S; Miyoshi K; Higo H; Kurosaki T; Otani S; Sugimoto S; Yamane M; Kiura K; Toyooka S; Oto T
Respir Investig; 2019 Mar; 57(2):165-171. PubMed ID: 30600175
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
Ohkubo H; Kunii E; Moriyama S; Niimi A
Respir Investig; 2015 Jan; 53(1):45-7. PubMed ID: 25542603
[No Abstract] [Full Text] [Related]
13. Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience.
Isshiki T; Sakamoto S; Yamasaki A; Shimizu H; Miyoshi S; Nakamura Y; Homma S; Kishi K
Respir Med; 2021 Oct; 187():106551. PubMed ID: 34343721
[TBL] [Abstract][Full Text] [Related]
14. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer.
Mizuno Y; Iwata H; Shirahashi K; Takamochi K; Oh S; Suzuki K; Takemura H
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e161-5. PubMed ID: 22504895
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
[TBL] [Abstract][Full Text] [Related]
16. [Successful resection of lung cancer with idiopathic pulmonary fibrosis treated by pirfenidone during perioperative period].
Shomura S; Katayama Y; Kusagawa H; Komada T
Kyobu Geka; 2013 Sep; 66(10):890-3. PubMed ID: 24008638
[TBL] [Abstract][Full Text] [Related]
17. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study.
Lee EG; Lee TH; Hong Y; Ryoo J; Heo JW; Gil BM; Kang HS; Kwon SS; Kim YH
PLoS One; 2021; 16(12):e0261684. PubMed ID: 34941933
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation.
Vianello A; Molena B; Turato C; Braccioni F; Arcaro G; Paladini L; Andretta M; Saetta M
Curr Med Res Opin; 2019 Jul; 35(7):1187-1190. PubMed ID: 30612467
[No Abstract] [Full Text] [Related]
20. Real-world experiences: Efficacy and tolerability of pirfenidone in clinical practice.
Fang C; Huang H; Guo J; Ferianc M; Xu Z
PLoS One; 2020; 15(1):e0228390. PubMed ID: 31999801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
